VPS26A
gene geneOn this page
Also known as Hbeta58PEP8A
Summary
VPS26A (VPS26 retromer complex component A, HGNC:12711) is a protein-coding gene on chromosome 10q22.1, encoding Vacuolar protein sorting-associated protein 26A (O75436). Acts as a component of the retromer cargo-selective complex (CSC).
This gene belongs to a group of vacuolar protein sorting (VPS) genes. The encoded protein is a component of a large multimeric complex, termed the retromer complex, involved in retrograde transport of proteins from endosomes to the trans-Golgi network. The close structural similarity between the yeast and human proteins that make up this complex suggests a similarity in function. Expression studies in yeast and mammalian cells indicate that this protein interacts directly with VPS35, which serves as the core of the retromer complex. Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 9559 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 43 total
- Druggable target: yes
- MANE Select transcript:
NM_004896
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12711 |
| Approved symbol | VPS26A |
| Name | VPS26 retromer complex component A |
| Location | 10q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Hbeta58, PEP8A |
| Ensembl gene | ENSG00000122958 |
| Ensembl biotype | protein_coding |
| OMIM | 605506 |
| Entrez | 9559 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 13 protein_coding, 4 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000263559, ENST00000373382, ENST00000395098, ENST00000467852, ENST00000489656, ENST00000489794, ENST00000490696, ENST00000497022, ENST00000497564, ENST00000858432, ENST00000858433, ENST00000858434, ENST00000858435, ENST00000940626, ENST00000940627, ENST00000940628, ENST00000940629, ENST00000949228
RefSeq mRNA: 5 — MANE Select: NM_004896
NM_001035260, NM_001318944, NM_001318945, NM_001318946, NM_004896
CCDS: CCDS41536, CCDS7286
Canonical transcript exons
ENST00000263559 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003483920 | 69171156 | 69174412 |
| ENSE00003489679 | 69168489 | 69168631 |
| ENSE00003541904 | 69155812 | 69155887 |
| ENSE00003546494 | 69158047 | 69158211 |
| ENSE00003570825 | 69166042 | 69166110 |
| ENSE00003611490 | 69132898 | 69133047 |
| ENSE00003645793 | 69157007 | 69157163 |
| ENSE00003690460 | 69162406 | 69162512 |
| ENSE00003842145 | 69124178 | 69124280 |
Expression profiles
Bgee: expression breadth ubiquitous, 301 present calls, max score 98.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 41.0115 / max 1130.1496, expressed in 1810 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 105322 | 40.7351 | 1810 |
| 105321 | 0.2764 | 96 |
Top tissues by expression
301 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parietal pleura | UBERON:0002400 | 98.62 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 98.58 | gold quality |
| parotid gland | UBERON:0001831 | 98.55 | gold quality |
| visceral pleura | UBERON:0002401 | 98.55 | gold quality |
| pleura | UBERON:0000977 | 98.52 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 98.34 | gold quality |
| upper leg skin | UBERON:0004262 | 98.28 | gold quality |
| skin of hip | UBERON:0001554 | 98.15 | gold quality |
| endothelial cell | CL:0000115 | 98.12 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.10 | gold quality |
| oral cavity | UBERON:0000167 | 98.04 | gold quality |
| cauda epididymis | UBERON:0004360 | 98.02 | gold quality |
| squamous epithelium | UBERON:0006914 | 98.00 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 97.97 | gold quality |
| renal glomerulus | UBERON:0000074 | 97.94 | gold quality |
| lower lobe of lung | UBERON:0008949 | 97.94 | gold quality |
| gingiva | UBERON:0001828 | 97.91 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 97.88 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 97.88 | gold quality |
| gingival epithelium | UBERON:0001949 | 97.84 | gold quality |
| colonic mucosa | UBERON:0000317 | 97.80 | gold quality |
| eye | UBERON:0000970 | 97.80 | gold quality |
| corpus epididymis | UBERON:0004359 | 97.80 | gold quality |
| caput epididymis | UBERON:0004358 | 97.75 | gold quality |
| mammalian vulva | UBERON:0000997 | 97.51 | gold quality |
| cerebellar vermis | UBERON:0004720 | 97.49 | gold quality |
| nephron tubule | UBERON:0001231 | 97.46 | gold quality |
| blood vessel layer | UBERON:0004797 | 97.45 | gold quality |
| hair follicle | UBERON:0002073 | 97.44 | gold quality |
| mammary duct | UBERON:0001765 | 97.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): VPS35
miRNA regulators (miRDB)
108 targeting VPS26A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
Literature-anchored findings (GeneRIF, showing 15)
- These observations indicate that the mammalian retromer complex assembles by sequential association of SNX1/2 and Vps26-Vps29-Vps35 subcomplexes on endosomal membranes and that SNX1 and SNX2 play interchangeable but essential roles. (PMID:17101778)
- Membrane recruitment of the cargo-selective retromer subcomplex VPS35/29/26 is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. (PMID:19531583)
- Colocalization of Vps26 paralogues with different endosomally located Rab proteins shows prolonged association of Vps26B-retromer with maturing endosomes relative to Vps26A-retromer. (PMID:21920005)
- Rabankyrin-5 interacts with EHD1 and Vps26 to regulate endocytic trafficking and retromer function (PMID:22284051)
- Mutations in VPS26A are not a frequent cause of Parkinson’s disease. (PMID:24417787)
- Mutations in the gene composing the retromer cargo recognition subunit are not a common cause of Parkinson’s disease. (PMID:24684791)
- VPS26A binding increases the affinity of the SNX27 PDZ domain for PDZ- binding motifs by an order of magnitude, revealing cooperativity in cargo selection. (PMID:25136126)
- provides molecular insights into the essential role of Vps26 and Vps35 in Rab7-mediated recruitment of the core retromer complex (PMID:25367362)
- Mutagenesis studies coupled with coimmunoprecipitations revealed that retromer-mediated trafficking requires the Env cytoplasmic tail that we show binds directly to retromer components Vps35 and Vps26. (PMID:25393110)
- This study demonstrated that Genetic variability of VPS26A in parkinsonism. (PMID:25475142)
- The retromer complex is a highly conserved membrane trafficking assembly composed of three proteins - Vps26, Vps29 and Vps35, which are impaired in neurodegenerative diseases. (Review) (PMID:26965691)
- We investigated the modification of air pollution and diabetes association by a genetic risk score covering 63 T2D genes. Five single variants near GRB14, UBE2E2, PTPRD, VPS26A and KCNQ1 showed nominally significant interactions with PM10 (P<0.05). Our results suggest that genetic risk for T2D may modify susceptibility to air pollution through alterations in insulin sensitivity. (PMID:27281273)
- X-ray crystallographic analysis of a 4-component complex comprising the VPS26 & VPS35 subunits of retromer, sorting nexin SNX3, & recycling signal from the divalent cation transporter DMT1-II; analysis identifies a binding site for canonical recycling signals at the interface between VPS26 & SNX3; shows cooperative interactions among the VPS subunits, SNX3 & cargo that couple signal-recognition to membrane recruitment. (PMID:27889239)
- Novel crosstalk between Vps26a and Nox4 signaling during neurogenesis. (PMID:30464227)
- The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma. (PMID:36834898)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vps26a | ENSDARG00000056549 |
| mus_musculus | Vps26a | ENSMUSG00000020078 |
| rattus_norvegicus | Vps26a | ENSRNOG00000030683 |
| caenorhabditis_elegans | WBGENE00006931 |
Paralogs (2): VPS26B (ENSG00000151502), VPS26C (ENSG00000157538)
Protein
Protein identifiers
Vacuolar protein sorting-associated protein 26A — O75436 (reviewed: O75436)
Alternative names: Vesicle protein sorting 26A
All UniProt accessions (3): O75436, S4R2Y3, S4R3Q6
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway. The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5. Required for retrograde transport of lysosomal enzyme receptor IGF2R. Required to regulate transcytosis of the polymeric immunoglobulin receptor (pIgR-pIgA). Required for the endosomal localization of WASHC2A (indicative for the WASH complex). Required for the endosomal localization of TBC1D5. Mediates retromer cargo recognition of SORL1 and is involved in trafficking of SORL1 implicated in sorting and processing of APP. Involved in retromer-independent lysosomal sorting of F2R. Involved in recycling of ADRB2. Enhances the affinity of SNX27 for PDZ-binding motifs in cargo proteins.
Subunit / interactions. Component of the heterotrimeric retromer cargo-selective complex (CSC), also described as vacuolar protein sorting subcomplex (VPS), formed by VPS26 (VPS26A or VPS26B), VPS29 and VPS35. The CSC has a highly elongated structure with VPS26 and VPS29 binding independently at opposite distal ends of VPS35 as central platform. The CSC is believed to associate with variable sorting nexins to form functionally distinct retromer complex variants. The originally described retromer complex (also called SNX-BAR retromer) is a pentamer containing the CSC and a heterodimeric membrane-deforming subcomplex formed between SNX1 or SNX2 and SNX5 or SNX6 (also called SNX-BAR subcomplex); the respective CSC and SNX-BAR subcomplexes associate with low affinity. The CSC associates with SNX3 to form a SNX3-retromer complex. The CSC associates with SNX27, the WASH complex and the SNX-BAR subcomplex to form the SNX27-retromer complex. Interacts with VPS29, VPS35, SNX1, SNX2, SNX5, SNX6, SNX3, SNX27, RAB7A, ECPAS, EHD1, WASHC5, SORL1.
Subcellular location. Cytoplasm. Endosome membrane. Early endosome.
Induction. Down-regulated in Alzheimer disease. No polymorphism or variant is however associated with Alzheimer disease for VPS26A.
Similarity. Belongs to the VPS26 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75436-1 | 1 | yes |
| O75436-2 | 2 |
RefSeq proteins (5): NP_001030337, NP_001305873, NP_001305874, NP_001305875, NP_004887* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR014752 | Arrestin-like_C_sf | Homologous_superfamily |
| IPR028934 | Vps26-related | Family |
Pfam: PF03643
UniProt features (39 total): strand 22, helix 4, sequence conflict 4, turn 3, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, splice variant 1, mutagenesis site 1
Structure
Experimental structures (PDB)
6 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2FAU | X-RAY DIFFRACTION | 2.1 |
| 5F0J | X-RAY DIFFRACTION | 2.7 |
| 5F0P | X-RAY DIFFRACTION | 2.78 |
| 5F0M | X-RAY DIFFRACTION | 3.1 |
| 5F0L | X-RAY DIFFRACTION | 3.2 |
| 7BLO | ELECTRON MICROSCOPY | 9.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75436-F1 | 87.92 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 315
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 235–236 | abolishes interaction with vps35 and endosomal subcellular location. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-3238698 | WNT ligand biogenesis and trafficking |
MSigDB gene sets: 213 (showing top):
GOBP_REGULATION_OF_AUTOPHAGY, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, CMYB_01, MORF_HDAC1, MORF_HDAC2, GOBP_VESICLE_MEDIATED_TRANSPORT, CACCAGC_MIR138, GOBP_MACROAUTOPHAGY, GOBP_REGULATION_OF_CATABOLIC_PROCESS, MORF_RAB6A, USF_01, NRF2_Q4, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_ENDOCYTIC_RECYCLING, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI
GO Biological Process (5): intracellular protein transport (GO:0006886), regulation of macroautophagy (GO:0016241), endocytic recycling (GO:0032456), retrograde transport, endosome to Golgi (GO:0042147), protein transport (GO:0015031)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (11): lysosome (GO:0005764), endosome (GO:0005768), early endosome (GO:0005769), cytosol (GO:0005829), endosome membrane (GO:0010008), retromer complex (GO:0030904), retromer, cargo-selective complex (GO:0030906), vesicle (GO:0031982), tubular endosome (GO:0097422), cytoplasm (GO:0005737), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Signaling by WNT | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| endosome | 3 |
| intracellular protein localization | 2 |
| endosomal transport | 2 |
| endomembrane system | 2 |
| membrane protein complex | 2 |
| protein transport | 1 |
| intracellular transport | 1 |
| regulation of autophagy | 1 |
| macroautophagy | 1 |
| vesicle-mediated transport to the plasma membrane | 1 |
| intercellular transport | 1 |
| cytosolic transport | 1 |
| transport | 1 |
| establishment of protein localization | 1 |
| binding | 1 |
| lytic vacuole | 1 |
| cytoplasmic vesicle | 1 |
| cytoplasm | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| retromer complex | 1 |
| membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1950 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VPS26A | SNX1 | Q13596 | 999 |
| VPS26A | VPS35 | Q96QK1 | 999 |
| VPS26A | VPS29 | Q9UBQ0 | 999 |
| VPS26A | SNX2 | P82862 | 994 |
| VPS26A | SNX27 | Q96L92 | 986 |
| VPS26A | SNX5 | Q9Y5X3 | 986 |
| VPS26A | SNX3 | O60493 | 982 |
| VPS26A | SNX6 | Q9UNH7 | 941 |
| VPS26A | SORL1 | Q92673 | 931 |
| VPS26A | TBC1D5 | Q92609 | 910 |
| VPS26A | SERPINE2 | P07093 | 843 |
| VPS26A | SORT1 | Q99523 | 766 |
| VPS26A | SNX4 | O95219 | 762 |
| VPS26A | WASHC5 | Q12768 | 753 |
| VPS26A | ANXA7 | P20073 | 752 |
IntAct
130 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VPS35 | VPS26A | psi-mi:“MI:0915”(physical association) | 0.980 |
| VPS26A | VPS35 | psi-mi:“MI:0915”(physical association) | 0.980 |
| VPS35 | VPS26A | psi-mi:“MI:0914”(association) | 0.980 |
| VPS35 | VPS26A | psi-mi:“MI:0407”(direct interaction) | 0.980 |
| VPS26A | VPS35 | psi-mi:“MI:0914”(association) | 0.980 |
| VPS26A | VPS35 | psi-mi:“MI:0403”(colocalization) | 0.980 |
| VPS26A | VPS29 | psi-mi:“MI:0915”(physical association) | 0.930 |
| VPS29 | VPS26A | psi-mi:“MI:0914”(association) | 0.930 |
| VPS29 | VPS26A | psi-mi:“MI:0915”(physical association) | 0.930 |
| VPS26A | TBC1D5 | psi-mi:“MI:0914”(association) | 0.810 |
| TBC1D5 | VPS26A | psi-mi:“MI:0914”(association) | 0.810 |
| VPS29 | VPS26C | psi-mi:“MI:0914”(association) | 0.760 |
| ZSCAN12 | VPS26A | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS26A | MORF4L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFV2 | VPS26A | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS26A | VPS26B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (258): VPS29 (Affinity Capture-MS), VPS35 (Affinity Capture-MS), TBC1D5 (Affinity Capture-MS), VPS26B (Affinity Capture-MS), VPS26A (Affinity Capture-MS), VPS26A (Reconstituted Complex), VPS26A (Reconstituted Complex), VPS26A (Co-fractionation), VPS26A (Co-fractionation), VPS26A (Co-fractionation), VPS26A (Co-fractionation), VPS29 (Co-fractionation), VPS35 (Co-fractionation), VPS26A (Affinity Capture-MS), BCS1L (Affinity Capture-MS)
ESM2 similar proteins: A0A7J6K9S4, A5PF44, C4R360, C5DL84, C5DRZ0, O01258, O17972, O45782, O75436, P30647, P40335, P40336, P53179, Q02331, Q09219, Q0VD53, Q10243, Q17388, Q18268, Q19829, Q28HT6, Q4G0F5, Q55CA0, Q5BKM4, Q5R436, Q5RAV3, Q68F29, Q6AY86, Q6CTM7, Q6DFB9, Q6DFU4, Q6DH23, Q6DTM3, Q6FWV1, Q6IRD0, Q6PAW0, Q6PB19, Q6PBN2, Q6TNP8, Q754G2
Diamond homologs: O01258, O75436, P40335, P40336, Q0VD53, Q10243, Q28HT6, Q4G0F5, Q55CA0, Q5BKM4, Q5R436, Q68F29, Q6AY86, Q6DFB9, Q6DFU4, Q6DH23, Q6IRD0, Q6TNP8, Q7ZV03, Q8C0E2, Q8I4T1, Q9FJD0, Q9T091, Q9W552
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 93 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| retrograde transport, endosome to Golgi | 9 | 23.4× | 1e-07 |
| endocytic recycling | 5 | 16.9× | 2e-03 |
| protein transport | 11 | 6.1× | 4e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1533 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:69123785:G:GT | donor_gain | 1.0000 |
| 10:69132891:A:AG | acceptor_gain | 1.0000 |
| 10:69132895:CAG:C | acceptor_gain | 1.0000 |
| 10:69132896:A:AG | acceptor_gain | 1.0000 |
| 10:69132896:AGA:A | acceptor_gain | 1.0000 |
| 10:69132897:G:GA | acceptor_gain | 1.0000 |
| 10:69132897:GA:G | acceptor_gain | 1.0000 |
| 10:69132897:GAG:G | acceptor_gain | 1.0000 |
| 10:69132897:GAGT:G | acceptor_gain | 1.0000 |
| 10:69132897:GAGTT:G | acceptor_gain | 1.0000 |
| 10:69133044:A:T | donor_gain | 1.0000 |
| 10:69133044:AAAGG:A | donor_loss | 1.0000 |
| 10:69133046:AGG:A | donor_loss | 1.0000 |
| 10:69133049:T:G | donor_loss | 1.0000 |
| 10:69156995:A:AG | acceptor_gain | 1.0000 |
| 10:69156996:A:G | acceptor_gain | 1.0000 |
| 10:69156997:A:AG | acceptor_gain | 1.0000 |
| 10:69157005:A:AG | acceptor_gain | 1.0000 |
| 10:69157005:AGAAC:A | acceptor_loss | 1.0000 |
| 10:69157006:G:GA | acceptor_loss | 1.0000 |
| 10:69157006:G:GG | acceptor_gain | 1.0000 |
| 10:69157006:GA:G | acceptor_gain | 1.0000 |
| 10:69157006:GAA:G | acceptor_gain | 1.0000 |
| 10:69157050:A:AG | acceptor_gain | 1.0000 |
| 10:69157051:G:GG | acceptor_gain | 1.0000 |
| 10:69157159:TTGAG:T | donor_loss | 1.0000 |
| 10:69157160:TGAG:T | donor_loss | 1.0000 |
| 10:69157161:GAGGT:G | donor_loss | 1.0000 |
| 10:69157162:AGGTA:A | donor_loss | 1.0000 |
| 10:69157163:GGTA:G | donor_loss | 1.0000 |
AlphaMissense
2170 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:69133037:T:A | V48D | 1.000 |
| 10:69133043:G:A | G50E | 1.000 |
| 10:69155878:G:C | G74R | 1.000 |
| 10:69155879:G:A | G74D | 1.000 |
| 10:69157039:T:C | F88L | 1.000 |
| 10:69157041:T:A | F88L | 1.000 |
| 10:69157041:T:G | F88L | 1.000 |
| 10:69157109:T:C | F111S | 1.000 |
| 10:69157154:T:A | V126D | 1.000 |
| 10:69158112:T:A | V151D | 1.000 |
| 10:69158157:T:A | M166K | 1.000 |
| 10:69158157:T:C | M166T | 1.000 |
| 10:69158157:T:G | M166R | 1.000 |
| 10:69158158:G:A | M166I | 1.000 |
| 10:69158158:G:C | M166I | 1.000 |
| 10:69158158:G:T | M166I | 1.000 |
| 10:69158159:G:A | E167K | 1.000 |
| 10:69158162:G:A | V168M | 1.000 |
| 10:69158162:G:C | V168L | 1.000 |
| 10:69158162:G:T | V168L | 1.000 |
| 10:69158163:T:A | V168E | 1.000 |
| 10:69158163:T:C | V168A | 1.000 |
| 10:69158165:G:A | G169S | 1.000 |
| 10:69158165:G:C | G169R | 1.000 |
| 10:69158165:G:T | G169C | 1.000 |
| 10:69158166:G:A | G169D | 1.000 |
| 10:69158166:G:T | G169V | 1.000 |
| 10:69158169:T:A | I170N | 1.000 |
| 10:69158169:T:G | I170S | 1.000 |
| 10:69158181:T:A | L174Q | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000036974 (10:69135171 C>T), RS1000086328 (10:69166532 A>G), RS1000194877 (10:69137845 T>G), RS1000225815 (10:69137986 A>T), RS1000254431 (10:69129547 A>G), RS1000255813 (10:69122787 C>A,G), RS1000295947 (10:69170549 G>A), RS1000336874 (10:69142162 C>G,T), RS1000441816 (10:69151836 A>G,T), RS1000455328 (10:69162104 G>A), RS1000524046 (10:69136568 CT>C), RS1000604866 (10:69129205 A>C,G), RS1000723719 (10:69147970 C>T), RS1000758011 (10:69169721 G>A), RS1000930705 (10:69140529 G>A)
Disease associations
OMIM: gene MIM:605506 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001213_3 | Type 2 diabetes | 4.000000e-08 |
| GCST001533_13 | Immune reponse to smallpox (secreted IL-1beta) | 1.000000e-09 |
| GCST002110_3 | Glycemic traits (pregnancy) | 1.000000e-22 |
| GCST007847_98 | Type 2 diabetes | 3.000000e-09 |
| GCST010989_84 | Body size at age 10 | 2.000000e-10 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004645 | response to vaccine |
| EFO:0004873 | cytokine measurement |
| EFO:0004307 | glucose tolerance test |
| EFO:0009819 | comparative body size at age 10, self-reported |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067011 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, affects response to substance | 2 |
| Tobacco Smoke Pollution | increases expression, affects expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, affects response to substance | 2 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylparaben | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| chloropicrin | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| nutlin 3 | affects cotreatment, increases secretion | 1 |
| bisphenol B | increases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Benzene | increases expression | 1 |
| Caffeine | affects phosphorylation | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases secretion | 1 |
| Endosulfan | decreases expression | 1 |
| Etoposide | affects expression | 1 |
| Hydrogen Peroxide | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652811 | Binding | Binding affinity to human VPS26A incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TX51 | HAP1 VPS26A (-) 1 | Cancer cell line | Male |
| CVCL_TX52 | HAP1 VPS26A (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.